| Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors H Han, Q Ma, C Li, R Liu, L Zhao, W Wang, P Zhang, X Liu, G Gao, F Liu, ... Emerging microbes & infections 9 (1), 1123-1130, 2020 | 1246 | 2020 |
| Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA J Lucifora, Y Xia, F Reisinger, K Zhang, D Stadler, X Cheng, MF Sprinzl, ... Science 343 (6176), 1221-1228, 2014 | 1077 | 2014 |
| Interferon-γ and tumor necrosis factor-α produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis Y Xia, D Stadler, J Lucifora, F Reisinger, D Webb, M Hösel, T Michler, ... Gastroenterology 150 (1), 194-205, 2016 | 370 | 2016 |
| Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages X Cheng, Y Xia, E Serti, PD Block, M Chung, K Chayama, B Rehermann, ... Hepatology 66 (6), 1779-1793, 2017 | 166 | 2017 |
| Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions Y Xia, A Carpentier, X Cheng, PD Block, Y Zhao, Z Zhang, U Protzer, ... Journal of hepatology 66 (3), 494-503, 2017 | 132 | 2017 |
| Clinical characteristics of COVID‐19 patients with hepatitis B virus infection—a retrospective study R Liu, L Zhao, X Cheng, H Han, C Li, D Li, A Liu, G Gao, F Zhou, F Liu, ... Liver International 41 (4), 720-730, 2021 | 70 | 2021 |
| Hepatitis B virus deregulates the cell cycle to promote viral replication and a premalignant phenotype Y Xia, X Cheng, Y Li, K Valdez, W Chen, TJ Liang Journal of virology 92 (19), 10.1128/jvi. 00722-18, 2018 | 67 | 2018 |
| Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection X Cheng, T Uchida, Y Xia, R Umarova, CJ Liu, PJ Chen, A Gaggar, V Suri, ... The Journal of Clinical Investigation 130 (6), 3205-3220, 2020 | 51 | 2020 |
| Descriptive, retrospective study of the clinical characteristics of asymptomatic COVID-19 patients H Han, Z Xu, X Cheng, Y Zhong, L Yuan, F Wang, Y Li, F Liu, Y Jiang, ... MSphere 5 (5), 10.1128/msphere. 00922-20, 2020 | 50 | 2020 |
| Hepatitis B surface antigen activates unfolded protein response in forming ground glass hepatocytes of chronic hepatitis B Y Li, Y Xia, X Cheng, DE Kleiner, SM Hewitt, J Sproch, T Li, H Zhuang, ... Viruses 11 (4), 386, 2019 | 50 | 2019 |
| Secreted Interferon‐Inducible Factors Restrict Hepatitis B and C Virus Entry In Vitro Y Xia, X Cheng, CK Blossey, K Wisskirchen, K Esser, U Protzer Journal of immunology research 2017 (1), 4828936, 2017 | 35 | 2017 |
| PASylated interferon α efficiently suppresses hepatitis B virus and induces anti-HBs seroconversion in HBV-transgenic mice Y Xia, M Schlapschy, V Morath, N Roeder, EI Vogt, D Stadler, X Cheng, ... Antiviral Research 161, 134-143, 2019 | 31 | 2019 |
| Lentiviral hepatitis B pseudotype entry requires sodium taurocholate co-transporting polypeptide and additional hepatocyte-specific factors LW Meredith, K Hu, X Cheng, CR Howard, TF Baumert, P Balfe, ... Journal of General Virology 97 (1), 121-127, 2016 | 28 | 2016 |
| Limited disassembly of cytoplasmic hepatitis B virus nucleocapsids restricts viral infection in murine hepatic cells K Zhao, F Guo, J Wang, Y Zhong, J Yi, Y Teng, Z Xu, L Zhao, A Li, Z Wang, ... Hepatology 77 (4), 1366-1381, 2023 | 21 | 2023 |
| Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal and integration DNA in mouse and tree shrew models J Yi, X Lei, F Guo, Q Chen, X Chen, K Zhao, C Zhu, X Cheng, J Lin, H Yin, ... Antiviral Research 215, 105618, 2023 | 19 | 2023 |
| Hepatitis B virus hijacks TSG101 to facilitate egress via multiple vesicle bodies Y Zheng, M Wang, S Li, Y Bu, Z Xu, G Zhu, C Wu, K Zhao, A Li, Q Chen, ... PLoS pathogens 19 (5), e1011382, 2023 | 18 | 2023 |
| Hepatitis B virus core protein is not required for covalently closed circular DNA transcriptional regulation Y Zhong, C Wu, Z Xu, Y Teng, L Zhao, K Zhao, J Wang, W Wang, Q Zhan, ... Journal of Virology 96 (21), e01362-22, 2022 | 16 | 2022 |
| A novel mouse model harboring hepatitis B virus covalently closed circular DNA Z Xu, L Zhao, Y Zhong, C Zhu, K Zhao, Y Teng, X Cheng, Q Chen, Y Xia Cellular and molecular gastroenterology and hepatology 13 (4), 1001-1017, 2022 | 16 | 2022 |
| Hepatitis B virus targets lipid transport pathways to infect hepatocytes K Esser, X Cheng, JM Wettengel, J Lucifora, L Hansen-Palmus, K Austen, ... Cellular and molecular gastroenterology and hepatology 16 (2), 201-221, 2023 | 13 | 2023 |
| Liver biopsy of chronic hepatitis B patients indicates HBV integration profile may complicate the endpoint and effect of entecavir treatment M Zhang, H Zhang, X Cheng, X Wang, H Xu, X Gao, R Wu, D Zhang, ... Antiviral research 204, 105363, 2022 | 9 | 2022 |
